Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

29.0K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
29.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platform.

Molecular therapy. Advances·2026
Same author

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
Same author

Metabolic expenditure, neurodevelopment, and weight gain into early childhood after fetal growth restriction.

Scientific reports·2026
Same author

Sickle Cell Disease: Historical Overview and Current Therapies.

Prenatal diagnosis·2026
Same author

Evaluation of Maternal Safety Following Prenatal Cell and Gene Therapy for Hemophilia A.

Prenatal diagnosis·2026
Same author

Placental apelin expression is low in early-onset fetal growth restriction but there is no association between maternal circulating apelin and pregnancy outcome.

Placenta·2026

Related Experiment Video

Updated: Sep 1, 2025

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.3K

Regenerative medicine: prenatal approaches.

Paolo de Coppi1, Stavros Loukogeorgakis1, Cecilia Götherström2

  • 1Stem Cell and Regenerative Medicine Section, Department of Developmental Biology and Cancer Research and Teaching, Great Ormond Street Institute of Child Health, University College London, London, UK; Department of Specialist Neonatal and Paediatric Surgery, Great Ormond Street Institute of Child Health, University College London, London, UK.

The Lancet. Child & Adolescent Health
|August 13, 2022
PubMed
Summary

Regenerative medicine advances, including stem-cell and gene therapies, offer new hope for treating congenital and incurable pediatric diseases. Innovations in prenatal diagnostics and in-utero treatments are paving the way for future pediatric therapies.

More Related Videos

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

7.1K
Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.8K

Related Experiment Videos

Last Updated: Sep 1, 2025

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.3K
The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

7.1K
Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.8K

Area of Science:

  • Regenerative Medicine
  • Genomics
  • Paediatric Health

Background:

  • Recent advancements in genomic, stem-cell, and tissue-based technologies are driving progress in regenerative medicine.
  • Congenital and incurable pediatric diseases present significant challenges requiring novel therapeutic approaches.
  • Prenatal diagnostic and therapeutic strategies are emerging as critical areas of research.

Purpose of the Study:

  • To review recent advances and applications of regenerative medicine relevant to pediatric patients.
  • To highlight innovations in disease modeling and the development of new therapies for pediatric conditions.
  • To discuss the opportunities and challenges associated with prenatal and in-utero therapeutic approaches.

Main Methods:

  • Review of current literature on regenerative medicine, genomics, and stem-cell technologies.
  • Analysis of noninvasive prenatal screening methods, including maternal plasma fetal DNA analysis.
  • Examination of in-utero therapies such as stem-cell, gene, and gene-modified cell treatments.

Main Results:

  • Genomic and stem-cell innovations have improved disease modeling and therapeutic development for pediatric disorders.
  • Noninvasive prenatal testing using maternal plasma fetal DNA is becoming standard for genetic disorder screening.
  • In-utero stem-cell, gene, and cell-based therapies show early promise for various pediatric conditions.

Conclusions:

  • Regenerative medicine holds significant potential for treating congenital and incurable pediatric diseases.
  • Prenatal and in-utero approaches offer unique therapeutic opportunities but face technical and ethical hurdles.
  • Future directions include utilizing fetal cells for postnatal treatment and artificial placentas for ex-utero therapies.